Increased plasma C5b-9, C1rC1s-C1 inhibitor and C3bbP preceded ARDS development and resolution; plasma C5b-9 was more sensitive than C3a, C4a, C5a and CH50 (241, 291). This evidence concerns the gene C3 and acute respiratory distress syndrome.